Loss of imprinting of insulin-like growth factor 2 is associated with increased risk of lymph node metastasis and gastric corpus cancer

被引：0
|
作者：
Yang Lu
Ping Lu
Zhi Zhu
Huimian Xu
Xike Zhu
机构：
[1] China Medical University the Shengjing Hopital,Research Center for Medicine
[2] China Medial University the First Affiliated Hospital,Department of Surgical Oncology
来源：
Journal of Experimental & Clinical Cancer Research | / 28卷
关键词：
Gastric Cancer; Gastric Cancer Tissue; Differentially Methylated Region; CTCF Binding Site; Informative Case;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Clinicopathological characteristics of colorectal cancers with loss of imprinting of insulin-like growth factor 2
    Sasaki, Jun-ichi
    Konishi, Fumio
    Kawamura, Yutaka J.
    Kai, Toshihiro
    Takata, Osamu
    Tsukamoto, Toshihiko
    INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (01) : 80 - 83
  • [22] Loss of imprinting of insulin-like growth factor 2 (IGF2) in thymic tumours
    Paul, C. M.
    Sauer, C.
    Schalke, B.
    Marx, A.
    Belharazem, D.
    VIRCHOWS ARCHIV, 2014, 465 : S377 - S378
  • [23] Insulin-like growth factor: cancer risk
    Cannell, E
    EUROPEAN JOURNAL OF CANCER, 2004, 40 (10) : 1460 - 1460
  • [24] Aging and cancer-related loss of insulin-like growth factor 2 imprinting in the mouse and human prostate
    Fu, Vivian X.
    Dobosy, Joseph R.
    Desotelle, Joshua A.
    Almassi, Nima
    Ewald, Jonathan A.
    Srinivasan, Rajini
    Berres, Mark
    Svaren, John
    Weindruch, Richard
    Jarrard, David F.
    CANCER RESEARCH, 2008, 68 (16) : 6797 - 6802
  • [25] Loss of imprinting of insulin-like growth factor-2 gene and prognostic significance in superficial bladder cancer
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (03) : 83 - 83
  • [26] Loss of genomic imprinting of insulin-like growth factor 2 is strongly associated with cellular proliferation in normal hematopoietic cells
    Hofmann, WK
    Takeuchi, S
    Frantzer, MA
    Hoelzer, D
    Koeffler, HP
    EXPERIMENTAL HEMATOLOGY, 2002, 30 (04) : 318 - 323
  • [27] Gene therapy for colorectal cancer by an oncolytic adenovirus that targets loss of the insulin-like growth factor 2 imprinting system
    Zhen-Lin Nie
    Yu-Qin Pan
    Bang-Shun He
    Ling Gu
    Li-Ping Chen
    Rui Li
    Ye-Qiong Xu
    Tian-Yi Gao
    Guo-Qi Song
    Andrew R Hoffman
    Shu-Kui Wang
    Ji-Fan Hu
    Molecular Cancer, 11
  • [28] Gene therapy for colorectal cancer by an oncolytic adenovirus that targets loss of the insulin-like growth factor 2 imprinting system
    Nie, Zhen-Lin
    Pan, Yu-Qin
    He, Bang-Shun
    Gu, Ling
    Chen, Li-Ping
    Li, Rui
    Xu, Ye-Qiong
    Gao, Tian-Yi
    Song, Guo-Qi
    Hoffman, Andrew R.
    Wang, Shu-Kui
    Hu, Fan
    MOLECULAR CANCER, 2012, 11
  • [29] Loss of insulin-like growth factor II imprinting is a hallmark associated with enhanced chemo/radiotherapy resistance in cancer stem cells
    Zhao, Xin
    Liu, Xiaoliang
    Wang, Guanjun
    Wen, Xue
    Zhang, Xiaoying
    Hoffman, Andrew R.
    Li, Wei
    Hu, Ji-Fan
    Cui, Jiuwei
    ONCOTARGET, 2016, 7 (32) : 51349 - 51364
  • [30] Vascular endothelial growth factor C expression and lymph node metastasis are regulated by the type I insulin-like growth factor receptor
    Tang, YC
    Zhang, DL
    Fallavollita, L
    Brodt, P
    CANCER RESEARCH, 2003, 63 (06) : 1166 - 1171
12345